Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dont make me go back and dig up your half dozen unanswered questions I asked you.
I can dig them up with links included.
Now, where are the posts that prove im mad about something?
BUSTED! Just because your name is on a selling stockholder list DOES NOT mean you are selling stock.
Ahhhhh, admitted name is on the list, then dont lie and say you dont have an agenda alright?
ALRIGHT?
Heres a reality check. Point out specifically in ANY of my posts that leads anyone to be believe im mad about something.
Go ahead. Lets see you point the diff between DD/facts/astute observation and mad.
WAITING
And Wtf is my agenda ?? I have none. Dont lie. Youve admitted participating in more than one private placement.
Hmmm, see anybody familiar on this Name of Selling Stockholder list?
https://www.sec.gov/Archives/edgar/data/1175680/000110465923080035/tm2316036-3_424b3.htm
Just shut up loser and limp back to the hangout spot more broke today then you were a week ago.
11/09 will be the day when you bums get your arms twisted into voting 400M more dilution while Cyrus gets his $300K hush money check.
Naw misiu, nobody is saying marksh1 or his doctor is a fraudster.
So dont lie and try to drag him down with you.
If these pumpers hadnt invested in/duped into buying they wouldnt know if leronsaline existed or not.
Theyre just trying to recoup massive losses.
Scientific evidence be damned according to them.
Dr Avish Nagpal said---
But he also stressed that the role the drug may have played in that recovery is unclear.
"We have had apparent success with this patient and I'm happy she did well, but I'm not going to let my ego get ahead of myself. I still want to stick to science and I still want to see data," said Avish Nagpal, a doctor who specializes in infectious disease who is also the medical director for infection prevention at Sanford Health.
At least your story was published in a local newspaper article with both photographs of you and your wife and quoted the attending physician and named the hospital in the article.... I'll give you that one.
Couple of questions---
Was your wife given all 4 approved treatments?
Why did the physician Avish Nagpal say he worked with the FDA to secure leronlimab?
A doctor at Sanford Health in Fargo who treated ************** and who worked with the FDA to secure leronlimab for her, says he is happy she is recovering.
But he also stressed that the role the drug may have played in that recovery is unclear.
"We have had apparent success with this patient and I'm happy she did well, but I'm not going to let my ego get ahead of myself. I still want to stick to science and I still want to see data," said Avish Nagpal, a doctor who specializes in infectious disease who is also the medical director for infection prevention at Sanford Health.
3. Does FDA review or approve the Right to Try Act requests?
A: FDA does not review or approve requests for Right to Try Act use. FDA’s role is limited to receipt and posting of certain information submitted under the Right to Try Act.
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
Agree, sub 20 cents is starting to have an effect.
See folks, longs/pumpers have nothing good to say about the co and this is absolute proof of how they choose to spend their day on the CYDY message board.
Just take a peek at the threads below.
Now ask yourselves this- Would you feel comfortable risking your investment dollar even if its sitting at 17 cents?
Leronlimab saved his life Was that confirmed by the 2 doctors you claimed signed the Right To Try papers or not?
Deflection and lies in 5 4 3 2 1....
Finally, a direct answer--- no, they can’t offer anything to anybody right now because nothing is approved
So youre invested in a co where nothing is approved, on FDA hold for almost 2 years, no CEO, and needs 400M more dilutive shares right?
RIGHT?
EXACTLY! Mooskank admits right here her son is young and healthy---
Yes , my son is younger and healthy , and our severe patients in CD12 were mostly over 65 , it was disproportional also with placebo I remember.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165390134
Just admit CYDY DOES NOT have anything to offer the world right now today and shut the F up.
Aside from your little rant, does CYDY have anything to offer the world right now today or not?
Yes or No?
First, answer this question I asked you a week ago---
Yes, lets talk about the company...what do they have to offer the world right now today?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172927088
Daaaang. Now mooskank broke and in trouble.
"YES" So thats one lie laid to rest...hospital said no cytokine storm.
Article said---
The surrounding hospitals were all full capacity so the resourceful mom called around looking for open beds. Eventually he was admitted to another hospital with a compassionate doctor leading the treatment. The first treatment offered was Remdesivir and that was patently rejected by the mom who read the reports and understood it was not appropriate for her son's situation. This was a cytokine storm not a viral infection. She made it known that she wanted leronlimab to be used for her son.
But but but isnt bilateral Covid pneumonia a viral infection?
Your quote- Yes , bilateral Covid pneumonia
See how the lies are easily starting to fall apart?
You posted your sons xrays showed double lobe pneumonia and was sent home without so much as being given an aspirin.
Then the article said it was a cytokine storm.
Tell the truth for once, the hospital NEVER said cytokine storm right?
RIGHT?
No link just as everyone here predicted.
The whole lazarus boy story is a total and complete lie or 2 attending Florida doctors and CYDY violated the Right To Try Act.
Where is the LINK stating the 4 approved drugs are not required and you can just randomly pick only 1 under the Right To Try Act?
WAITING
Right To Try Act sink in yet?
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
https://www.fda.gov/media/133864/download
https://www.congress.gov/115/bills/s204/BILLS-115s204enr.pdf
We all know you have problems digesting facts for example the FDA rebuke and 82% not statistically significant and what nots.
Carry on in that fantasy dream world packed with lies.
Right To Try Act. Right here---
‘‘(B) who has exhausted approved treatment options
and is unable to participate in a clinical trial involving
the eligible investigational drug, as certified by a physician,
Please. Stop side-stepping the facts. ALL FOUR approved drugs are required by the Right To Try Act.
You dont get to pick and choose which drug you like the best.
Heres a sample letter. Scroll down to "Right to try consent template" and click the link---
https://ohrpp.research.ucla.edu/consent-templates/
CURRENTLY APPROVED PRODUCTS AND TREATMENTS
The FDA approved products and treatments available for your condition include [specify available treatments]. It is unlikely; however, that all currently approved and recognized usual treatments are likely to prolong your life.
Dont start lying wolfy. He received one drug and one drug only.
4 are required, all FDA approved.
Just answer the question "DOCTOR". How was Right To Try granted by only administering ONE drug?
Um, misiu, how was Right To Try granted after only ONE approved option out of a total of FOUR REQUIRED approved options?
The Right to Try Act is one way for patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
Leronlimab Anecdotes - A Patient's Perspective - Beating the System
chessmaster's Photo
BY CHESSMASTER
THURSDAY, AUG 12, 2021 - 22:03
CytoDyn, appears to be the only biotech company with a proven treatment in a large randomized controlled trial for severe and critical COVID-19. Proven means their drug reduced 14 day mortality by 82% in a phase 3 clinical trial. Proven doesn't mean the drug is approved by the FDA because they asked for more data. This is the rub because it's proven, but not approved and because of that the company has been under constant assault and criticism for how the management team has been handling the clinical trials. Their leading drug candidate is called leronlimab and is branded as Vyrologix and it has single handedly taken dying from COVID-19 off the table. Many of the critics of the Company are shareholders and in one special case a group of shareholders that called themselves Advancing Leronlimab and used what the Company described and illegal tactics to challenge the board of directors. Luckily for patients around the world their bid for greed and avarice failed.
When you put aside the greed and take a hard look at the company, their mission statement is to save lives and of course maximize shareholder value. This management team may be tiny in comparison to most biotechs, but enormous in terms of heart. This team actually cares for patients personally and at one time in the pandemic had the largest number of compassionate use approvals. The truth is that there’s only one reason for breaking a record for compassionate use and it has to do with the viability of the treatment. Many that have gotten either compassionate use or the rarely used Right to Try approvals have interfaced with top management as they worked tirelessly to get the approvals processed as quickly as possible.
Shareholders that have a hard time understanding how a drug with so much potential isn't approved by now don't understand how challenging the drug development process is, and they certainly don’t understand a management that seems to put patients’ lives first. At CytoDyn the CEO has gotten himself personally involved in pushing the process of many Emergency IND’s and compassionate use requests. This is not a normal thing that people are likely to see at any other biotech on the globe. The corporate culture really values human life and seems to do anything they can to preserve it.
Leronlimab has saved many lives. A very recent anecdotal report of another life saved by leronlimab underscores the importance of how truly revolutionary this drug could become. In order to preserve the privacy of the patient no identifying details will be used. Approximately 2 weeks ago a mother in the medical field was talking to her grown son who is also in the medical field and noticed over the phone that he sounded sick and nasally. The son indicated that he just had a bad cold and that something was going around because he thought since all people were all wearing masks for so long that their natural immunity was compromised and colds were on the rise. The mom was skeptical of the answer and made him take a home covid test from the pharmacy. Although he tested positive, the mom was well versed in treatment options and was prepared. She pumped him up with ivermectin, vitamins and eventually resorted to hydroxychloroquine. Nothing seemed to work, and after a couple of days his oxygen levels eventually dropped into the mid 70’s forcing him to call an ambulance. When he arrived he found himself in an unfortunate situation. The Floridian healthcare system was experiencing a surge and was overrun with patients. After many hours of waiting he was diagnosed via a chest X ray having double lobe pneumonia, no treatment was administered and the son found his way back home after picking up a canister of oxygen to use at home. During his wait in the Emergency room he was not provided water, or intravenous fluids, or a bed to lay down on. Despite his use of oxygen at home his oxygen levels continued to deteriorate to 74%. He could barely breathe or talk. This put him at severe risk of dying, he needed to get back to the hospital. The surrounding hospitals were all full capacity so the resourceful mom called around looking for open beds. Eventually he was admitted to another hospital with a compassionate doctor leading the treatment. The first treatment offered was Remdesivir and that was patently rejected by the mom who read the reports and understood it was not appropriate for her son's situation. This was a cytokine storm not a viral infection. She made it known that she wanted leronlimab to be used for her son. Instead of saying no, the doctor suggested they try one of the approved options like tocilizumab first and see if there was any change before they go the Right to Try route. After 3 days of seeing continued deterioration the Right to Try paperwork was signed by the doctor. The drug made it to the hospital the very next day. This was very A-typical because the mom was completely prepared and was on top of the communication.
Before taking leronlimab the patient was on high flow oxygen consuming between 6 – 10 liters. Since leronlimab is a subcutaneous shot it takes time to enter the bloodstream and she cautioned her son to remain patient. After administration it took two hours before there was a change in his status. The patient was able to talk better and had a more productive cough and the oxygen saturation levels started to increase. After 4-5 hours oxygen levels improves so much high flow oxygen was removed and reduced to the nasal cannula. The patient's strength was coming back and he felt like leaving the hospital, but there was also pressure for him to leave to make room for the sick that were in the hallways. The patient was ultimately discharged 26 hours after being injected with leronlimab, and went home with instructions to use oxygen as needed and report back if there was a worsening of conditions.
All these anecdotal patients that took leronlimab, which numbers over 100 understand one truth. The drug works and works extremely well and in most cases quickly. The last thing these patients care about is the greed involved in developing a drug and the he said she said minutia in the boardroom. They welcome a CEO and a company with a refreshing attitude that just wants to save lives. Critically ill patients have been abandoned by both the FDA with their draconian policies and politicians whom seem to be more concerned about mandating vaccines and masks. Team CytoDyn and Hero moms need to be celebrated whenever possible.
The measures to curb the pandemic failed with over 620,000 American in body bags. Initial estimates were 200,000. History will eventually reflect upon how many lives that could have been saved if leronlimab was approved sooner. There is still a long approval road ahead for leronlimab in the United States, but Brazil has their own pivotal trial starting imminently and may be the first beneficiary of a COVID drug that takes dying off the table and flattens the curve.
The situation in Florida with respect to available ICU beds is really bad and here sits a drug that saves the lives of almost everyone it touches. It also has the potential to seriously flatten the curve in hard hit areas because if all the people sitting in the hallways were given this very safe drug they might actually go home like this patient did. People need to know about this drug and the process required to get it. Right now it's only available via Right to Try since it doesn't have its EUA approval or any active clinical trial sites in the USA. Eventually the FDA will come around to approving this drug but in the meantime it's pointless to provoke the FDA and try to force an approval. That's been tried before and has failed. People just need to work within the system to get the drug for your loved ones should they need it. The hero mom in this story was well educated and prepared on what to do in case of this eventuality. Advanced preparedness seems to be partly responsible for the happy ending. So the lesson learned here is that there is no substitute for preparation. It's clear that this drug takes dying off the table and when politicians decide they've seen enough body bags then maybe this drug will see the light of day for use in COVID-19 in the United States.
Right to Try is the only way to access leronlimab and take dying off the table for severe to critical patients. The only hitch is that you have to ask for it and you have to get a doctor at the hospital willing to step up. These anecdotal reports are just whispers right now, but they will turn into a thunderous call to action as the pandemic worsens and news of the drugs success continues to spread.
Duly noted. You admitted the article was about you and your son. Thank you.
I was glad I have again the article about my son , and what we went then , and how great our drug leronlimab is . This time I copied and paste , last time for some reason it was gone..
It was a very moving moment for me to read the story again, and after that , I became more patience now with waiting for it.
Yup. Either the Lazarus boy story was a total lie or 2 doctors and CYDY violated the Right To Try Act.
Its one or the other...no in between.
Um, misiu, Right To Try demands ALL approved treatment options be administered first right?
RIGHT?
The Right to Try Act is one way for patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain investigational treatment options. FDA’s role in implementing the Right to Try Act is limited to receiving and posting certain information submitted to the agency.
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
They started IV dexamethasone and IV antibiotics. also order remdesivir.
I told my son that there is no reason for this toxic drug as it will not help him at all.
So last night doctor , infectious disease call me from my son room , said that my son is to sick to wait for leronlimab even few days , and I
agreed , we need to give him something , so after talking about all approved drugs we decided on tocilizumab , hoping that he will not develop serious infection since both dexamethasone and tocilizumab are immunosuppressive drugs.
AHAHAHAHAHAAA!!! Me buy many stock me not like name-calling me call sec!
Whomever thought the zerohedge leronsaline pump was gone for good after removing it from zerohedge was HIGHLY mistaken.
It will eventually all come out in the proverbial wash.
Stay tuned.
Extra! Extra! Get your zerohedge Lazarus boy article right here folks!---
Leronlimab Anecdotes - A Patient's Perspective - Beating the System
BY CHESSMASTER
THURSDAY, AUG 12, 2021 - 22:03
CytoDyn, appears to be the only biotech company with a proven treatment in a large randomized controlled trial for severe and critical COVID-19. Proven means their drug reduced 14 day mortality by 82% in a phase 3 clinical trial. Proven doesn't mean the drug is approved by the FDA because they asked for more data. This is the rub because it's proven, but not approved and because of that the company has been under constant assault and criticism for how the management team has been handling the clinical trials. Their leading drug candidate is called leronlimab and is branded as Vyrologix and it has single handedly taken dying from COVID-19 off the table. Many of the critics of the Company are shareholders and in one special case a group of shareholders that called themselves Advancing Leronlimab and used what the Company described and illegal tactics to challenge the board of directors. Luckily for patients around the world their bid for greed and avarice failed.
When you put aside the greed and take a hard look at the company, their mission statement is to save lives and of course maximize shareholder value. This management team may be tiny in comparison to most biotechs, but enormous in terms of heart. This team actually cares for patients personally and at one time in the pandemic had the largest number of compassionate use approvals. The truth is that there’s only one reason for breaking a record for compassionate use and it has to do with the viability of the treatment. Many that have gotten either compassionate use or the rarely used Right to Try approvals have interfaced with top management as they worked tirelessly to get the approvals processed as quickly as possible.
Shareholders that have a hard time understanding how a drug with so much potential isn't approved by now don't understand how challenging the drug development process is, and they certainly don’t understand a management that seems to put patients’ lives first. At CytoDyn the CEO has gotten himself personally involved in pushing the process of many Emergency IND’s and compassionate use requests. This is not a normal thing that people are likely to see at any other biotech on the globe. The corporate culture really values human life and seems to do anything they can to preserve it.
Leronlimab has saved many lives. A very recent anecdotal report of another life saved by leronlimab underscores the importance of how truly revolutionary this drug could become. In order to preserve the privacy of the patient no identifying details will be used. Approximately 2 weeks ago a mother in the medical field was talking to her grown son who is also in the medical field and noticed over the phone that he sounded sick and nasally. The son indicated that he just had a bad cold and that something was going around because he thought since all people were all wearing masks for so long that their natural immunity was compromised and colds were on the rise. The mom was skeptical of the answer and made him take a home covid test from the pharmacy. Although he tested positive, the mom was well versed in treatment options and was prepared. She pumped him up with ivermectin, vitamins and eventually resorted to hydroxychloroquine. Nothing seemed to work, and after a couple of days his oxygen levels eventually dropped into the mid 70’s forcing him to call an ambulance. When he arrived he found himself in an unfortunate situation. The Floridian healthcare system was experiencing a surge and was overrun with patients. After many hours of waiting he was diagnosed via a chest X ray having double lobe pneumonia, no treatment was administered and the son found his way back home after picking up a canister of oxygen to use at home. During his wait in the Emergency room he was not provided water, or intravenous fluids, or a bed to lay down on. Despite his use of oxygen at home his oxygen levels continued to deteriorate to 74%. He could barely breathe or talk. This put him at severe risk of dying, he needed to get back to the hospital. The surrounding hospitals were all full capacity so the resourceful mom called around looking for open beds. Eventually he was admitted to another hospital with a compassionate doctor leading the treatment. The first treatment offered was Remdesivir and that was patently rejected by the mom who read the reports and understood it was not appropriate for her son's situation. This was a cytokine storm not a viral infection. She made it known that she wanted leronlimab to be used for her son. Instead of saying no, the doctor suggested they try one of the approved options like tocilizumab first and see if there was any change before they go the Right to Try route. After 3 days of seeing continued deterioration the Right to Try paperwork was signed by the doctor. The drug made it to the hospital the very next day. This was very A-typical because the mom was completely prepared and was on top of the communication.
Before taking leronlimab the patient was on high flow oxygen consuming between 6 – 10 liters. Since leronlimab is a subcutaneous shot it takes time to enter the bloodstream and she cautioned her son to remain patient. After administration it took two hours before there was a change in his status. The patient was able to talk better and had a more productive cough and the oxygen saturation levels started to increase. After 4-5 hours oxygen levels improves so much high flow oxygen was removed and reduced to the nasal cannula. The patient's strength was coming back and he felt like leaving the hospital, but there was also pressure for him to leave to make room for the sick that were in the hallways. The patient was ultimately discharged 26 hours after being injected with leronlimab, and went home with instructions to use oxygen as needed and report back if there was a worsening of conditions.
All these anecdotal patients that took leronlimab, which numbers over 100 understand one truth. The drug works and works extremely well and in most cases quickly. The last thing these patients care about is the greed involved in developing a drug and the he said she said minutia in the boardroom. They welcome a CEO and a company with a refreshing attitude that just wants to save lives. Critically ill patients have been abandoned by both the FDA with their draconian policies and politicians whom seem to be more concerned about mandating vaccines and masks. Team CytoDyn and Hero moms need to be celebrated whenever possible.
The measures to curb the pandemic failed with over 620,000 American in body bags. Initial estimates were 200,000. History will eventually reflect upon how many lives that could have been saved if leronlimab was approved sooner. There is still a long approval road ahead for leronlimab in the United States, but Brazil has their own pivotal trial starting imminently and may be the first beneficiary of a COVID drug that takes dying off the table and flattens the curve.
The situation in Florida with respect to available ICU beds is really bad and here sits a drug that saves the lives of almost everyone it touches. It also has the potential to seriously flatten the curve in hard hit areas because if all the people sitting in the hallways were given this very safe drug they might actually go home like this patient did. People need to know about this drug and the process required to get it. Right now it's only available via Right to Try since it doesn't have its EUA approval or any active clinical trial sites in the USA. Eventually the FDA will come around to approving this drug but in the meantime it's pointless to provoke the FDA and try to force an approval. That's been tried before and has failed. People just need to work within the system to get the drug for your loved ones should they need it. The hero mom in this story was well educated and prepared on what to do in case of this eventuality. Advanced preparedness seems to be partly responsible for the happy ending. So the lesson learned here is that there is no substitute for preparation. It's clear that this drug takes dying off the table and when politicians decide they've seen enough body bags then maybe this drug will see the light of day for use in COVID-19 in the United States.
Right to Try is the only way to access leronlimab and take dying off the table for severe to critical patients. The only hitch is that you have to ask for it and you have to get a doctor at the hospital willing to step up. These anecdotal reports are just whispers right now, but they will turn into a thunderous call to action as the pandemic worsens and news of the drugs success continues to spread.
First of all, a licensed physician crying to an internet message board asking about how to get a drug for a patient (relative) was another red flag.
You think thats bad, just wait till the Lazarus boy fraud is exposed via documented proof.
Fraud further exposed---For example Florida foreign trained doctors must demonstrate competency in English through presentation of the ECFMG English proficiency certificate or by a satisfactory grade on the Test of Spoken English of the Educational Testing Service or similar test approved by the rule of the board
https://www.joneshealthlaw.com/how-can-a-foreign-trained-doctor-obtain-a-florida-medical-license/#:~:text=If%20the%20language%20of%20instruction%20of%20the%20foreign,test%20approved%20by%20the%20rule%20of%20the%20board.
Assessment of Communication Skills, Including English Language Proficiency
As part of the Pathways, applicants are required to attain a satisfactory score on the Occupational English Test (OET) Medicine to satisfy the communication skills requirement for ECFMG Certification. All Pathways applicants, regardless of native language, language of instruction at medical school, or citizenship, must satisfy this requirement in addition to meeting the requirements of a specific Pathway. There will be no exceptions.
See the Assessment of Communications Skills, Including English Language Proficiency
https://www.ecfmg.org/certification-pathways/#oet
Assessment of Communication Skills, Including English Language Proficiency
Applicants who pursue one of the Pathways are required to attain a satisfactory score on the Occupational English Test (OET) Medicine to satisfy the communication skills requirement for ECFMG Certification. All Pathways applicants, regardless of native language, language of instruction at medical school, or citizenship, must satisfy this requirement. There will be no exceptions.
OET Medicine is designed specifically for physicians, in consultation with physicians. The test assesses the health care-specific English language competency and communication skills of physicians. It is more than a test of English language proficiency, emphasizing the type of language physicians will need to communicate effectively in a clinical setting with peers and patients. For more information on OET, please visit the ECFMG page on the OET website .
Passing Requirement
To meet ECFMG’s requirements:
Applicants who take OET Medicine before April 1, 2022 must attain a minimum score of 350 on each of the four measured sub-tests of OET Medicine (Listening, Reading, Writing, and Speaking) in one test administration.
Applicants who take OET Medicine on or after April 1, 2022 must attain a minimum score of 350 on the Listening, Reading, and Speaking sub-tests, and a minimum score of 300 on the Writing sub-test, in one test administration.
Applicants who do not attain the minimum score on one or more of the measured sub-tests must retake all OET Medicine sub-tests (Listening, Reading, Writing, and Speaking) and achieve the minimum score on all sub-tests in a single test administration.
https://www.ecfmg.org/certification-pathways/oet.html
Yep, after I pointed out to that fraud writing and speaking with a hard accent are two separate things mooskank dropped the me not know how to write english shtick.
NP spoke with a hard accent but at least wrote like he had a phd.
Plenty of MDs and DOs out there that speak with an accent but NEVER write a sentence that made them look like they didnt graduate elementary school.
Yes, lets talk about the company...what do they have to offer the world right now today?
They might have until the 13th of Oct or so to file it...not really sure---
6) Annual OTCQB Certification. The Company must file an annual OTCQB Certification signed
by either the CEO or CFO containing the statements required in Section 1.3(3) of these
Standards. The annual OTCQB Certification must be filed through the OTC Disclosure &
News Service no later than 45 calendar days after the Company’s Annual Report due date.
CYDY closed in da 17s...16s next.